Navigating Cystic Fibrosis Treatment in Pregnancy and Beyond

This chapter explores the usage of CFTR modulators in pregnant women and their implications for fetal health, particularly focusing on cystic fibrosis indicators like echogenic bowel. It also addresses the ethical considerations of expensive therapies, the need for comprehensive counseling for couples, and emphasizes the importance of ongoing research and risk assessments in managing rare diseases.